J. George

J. George, M. Mims, R. Kamble, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alteration of platelet function in dogs mediated by interleukin-6.

J. George, S. Burstein, G. Dale, 1994, Blood.

Platelets

J. George, 2000, The Lancet.

The Variety of Systemic Malignancies That Can Cause MAHA and Thrombocytopenia Misdiagnosed as TTP

J. George, 2017 .

Evaluation of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia

J. George, Roseleen S Charania, 2013, Seminars in Thrombosis & Hemostasis.

Systemic malignancies as a cause of unexpected microangiopathic hemolytic anemia and thrombocytopenia.

J. George, 2011, Oncology.

Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura–hemolytic uremic syndrome

S. Vesely, J. George, Deirdra R. Terrell, 2004, Transfusion.

The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

J. George, 2005, Clinical advances in hematology & oncology : H&O.

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.

S. Vesely, J. George, Deirdra R. Terrell, 2004, Seminars in hematology.

Isolation of human platelet membrane microparticles from plasma and serum.

J. George, L. McManus, L. McManus, 1982, Blood.

Pulmonary involvement in patients with thrombotic thrombocytopenic purpura

S. Vesely, J. George, T. Nokes, 2014, European journal of haematology.

Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

J. George, L. Aledort, M. Tarantino, 2010, Journal of thrombosis and haemostasis : JTH.

Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trials

J. George, R. Redner, D. Henry, 2009, British journal of haematology.

Approach to the diagnosis and management of drug-induced immune thrombocytopenia.

J. George, J. Kelton, James W. Smith, 2013, Transfusion medicine reviews.

Drug-Induced Thrombocytopenia

J. George, Z. Al-Nouri, 2007, Drug Safety.

Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery.

J. George, N. Kieffer, P. Newman, 1986, The Journal of clinical investigation.

Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia

J. George, Deirdra R. Terrell, 2008, Haematologica.

Chapter 9 – Immune Thrombocytopenic Purpura

J. George, K. Kojouri, 2007 .

Sequence of treatments for adults with primary immune thrombocytopenia

J. George, 2012, American journal of hematology.

Management of immune thrombocytopenia--something old, something new.

J. George, 2010, The New England journal of medicine.

Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept

Stephen A. Cohen, J. George, Joseph O. Moore, 2003, American journal of hematology.

How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

J. George, 2000, Blood.

Drug-Induced Thrombocytopenia

S. Vesely, J. George, Xiaoning Li, 1999, Drug safety.

Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency

J. George, C. C. Deford, Qiaofang Chen, 2012, Journal of clinical apheresis.

Platelets: thrombotic thrombocytopenic purpura.

J. George, B. Lämmle, J. Sadler, 2002, Hematology. American Society of Hematology. Education Program.

Ciclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long‐term follow‐up with serial analysis of ADAMTS13 activity

J. George, Shili Lin, E. Kraut, 2007, British journal of haematology.

The incidence of thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS‐13 deficiency

S. Vesely, J. George, B. Lämmle, 2005, Journal of thrombosis and haemostasis : JTH.

Is immune thrombocytopenic purpura less common among black Americans?

S. Vesely, J. George, Deirdra R. Terrell, 2005, Blood.

Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.

S. Vesely, J. George, B. Lämmle, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Maintenance rituximab for relapsing thrombotic thrombocytopenic purpura: a case report

J. George, R. Saleem, Z. Rogers, 2018, Transfusion.

Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries.

J. Armitage, J. George, G. Demetri, 2004, The American journal of medicine.

Management of antithrombotic therapy in adults with immune thrombocytopenia (ITP): a survey of ITP specialists and general hematologist–oncologists

S. Vesely, J. George, D. Cines, 2018, Journal of Thrombosis and Thrombolysis.

Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate.

J. George, R. Heinz, E. Pickett, 1986, Blood.

Platelet IgG, IgA, IgM, and Albumin: Correlation of Platelet and Plasma Concentrations in Normal Subjects and in Patients With ITP or Dysproteinemia

J. George, Sherry Saucerman, 1988 .

TTP: the evolution of clinical practice.

J. George, 2021, Blood.

Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.

J. George, S. Cataland, M. Loch, 2019, The New England journal of medicine.

Management of thrombotic thrombocytopenic purpura without plasma exchange: the Jehovah's Witness experience.

J. George, S. A. Sandler, J. Stankiewicz, 2017, Blood advances.

Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial

S. Vesely, J. George, J. Kiss, 2017, Transfusion.

Measuring ADAMTS13 activity in patients with suspected thrombotic thrombocytopenic purpura: when, how, and why?

J. George, 2015, Transfusion.

The Oklahoma thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome Registry

J. George, C. C. Deford, K. Lu, 2013, Hämostaseologie.

Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes.

J. George, Z. Al-Nouri, 2012, Hematology. American Society of Hematology. Education Program.

Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura

J. George, 2012, American journal of hematology.

ADAMTS13 Alone.

J. George, 2010, Blood.

Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura

S. Vesely, J. George, B. Lämmle, 2009, Transfusion.

ADAMTS13: what it does, how it works, and why it's important

J. George, 2009, Transfusion.

The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007.

J. George, 2009, Kidney international. Supplement.

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder

J. George, 2008, Bone Marrow Transplantation.

Thrombotic thrombocytopenic purpura: 2008 update.

J. George, M. Crowther, 2008, Cleveland Clinic journal of medicine.

Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease

J. George, B. Lämmle, J. K. Kremer Hovinga, 2008, Haematologica.

Twice‐daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006

S. Vesely, J. George, Deirdra R. Terrell, 2007, Transfusion.

Lessons learned from the Oklahoma Thrombotic Thrombocytopenic Purpura‐Hemolytic Uremic Syndrome Registry

S. Vesely, J. George, Deirdra R. Terrell, 2008, Journal of clinical apheresis.

Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation

J. George, K. Kojouri, 2007, Current opinion in oncology.

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh‐frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

J. George, P. Mintz, C. Hillyer, 2006, Transfusion.

Controlling chronic TTP

J. George, 2005 .

Occult systemic malignancy masquerading as thrombotic thrombocytopenic purpura- hemolytic uremic syndrome

J. George, K. Kojouri, Kristin K. Francis, 2005 .

The Oklahoma Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome Registry: a program for patient care, education and research

J. George, 2004 .

Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes

J. George, G. Selby, 2004, Bone Marrow Transplantation.

Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction.

J. George, B. Lämmle, 2004, Seminars in hematology.

Thrombotic thrombocytopenic purpura: a syndrome that keeps evolving

J. George, 2004, Journal of clinical apheresis.

Deficiency of ADAMTS‐13 in thrombotic and thrombocytopenic purpura

J. George, S. Vesely, 2003 .

The association of pregnancy with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome

J. George, 2003, Current opinion in hematology.

Thrombotic Thrombocytopenic Purpura: From the Bench to the Bedside, but Not Yet to the Community

S. Vesely, J. George, 2003, Annals of Internal Medicine.

Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome during pregnancy

J. George, J. McMinn, 2001, Journal of clinical apheresis.

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome

S. Vesely, J. George, L. Williams, 2006, Transfusion.

Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura‐hemolytic‐uremic syndrome

S. Vesely, J. George, M. Rizvi, 2000 .

How I treat How I treat patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome

J. George, 2000 .

Corticosteroid side‐effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives

S. Vesely, J. George, S. Kennison, 2009, European journal of haematology.

Thrombotic thrombocytopenic purpura: Crossing to safety

J. George, 2022, Transfusion.

Aspirin prophylaxis for hereditary and acquired thrombotic thrombocytopenic purpura?

J. George, L. Xia, Bojing Shao, 2022, American journal of hematology.

Deletion of platelet CLEC-2 decreases GPIbα-mediated integrin αIIbβ3 activation and decreases thrombosis in TTP

J. George, Junmei Chen, W. Bergmeier, 2022, Blood.

Post-transplant complications Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

S. Vesely, J. George, V. Roy, 2001 .

Increased urinary albumin excretion following recovery from thrombotic thrombocytopenic purpura due to acquired ADAMTS13 deficiency.

S. Vesely, J. George, D. Little, 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Studies on platelet plasma membranes. II. Characterization of surface proteins of rabbit platelets in vitro and during circulation in vivo using diazotized (125i)-diiodosulfanilic acid as a label.

J. George, D. Sears, P. Lewis, 1976, The Journal of laboratory and clinical medicine.

Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura

J. George, Shili Lin, E. Kraut, 2008, American journal of hematology.

Biotinylated platelets: a new approach to the measurement of platelet life span

J. George, S. Burstein, G. Dale, 1993, British journal of haematology.

Inhibition of the acute‐phase response in vivo by anti‐gp130 monoclonal antibodies

J. George, R. Wolf, S. Burstein, 1996, British journal of haematology.

Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency

S. Vesely, J. George, B. Lämmle, 2011, Transfusion.

Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease

J. George, J. Journeycake, Pengchun Yu, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Quantitative analysis of platelet membrane glycoproteins: effect of platelet washing procedures and isolation of platelet density subpopulations.

J. George, R. K. Morgan, L. L. Thoi, 1981, Thrombosis research.

Further characterization of calcium-accumulating vesicles from human blood platelets.

J. George, E. Lüscher, R. Käser-Glanzmann, 1978, Biochimica et biophysica acta.

Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura

S. Vesely, J. George, B. Lämmle, 2012, Haematologica.

Thrombotic thrombocytopenic purpura—hemolytic uremic syndrome (TTP‐HUS) following treatment with deoxycoformycin in a patient with cutaneous T‐cell lymphoma (Sezary syndrome): A case report

J. George, T. Pham, J. Leach, 1999, American journal of hematology.

Human Platelets Contain mRNA Transcripts for Platelet Factor 4 and Actin

J. George, D. Mosher, J. Sottile, 1989, Thrombosis and Haemostasis.

An evaluation of ciclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura

J. George, E. Kraut, A. Ferketich, 2007 .

Biological individuality and the new frontiers of immunological tolerance in hematopoietic stem cell transplantation

S. Vesely, J. George, B. Lämmle, 2010 .

Diagnostic Criteria for Hematopoietic Stem Cell Transplantation-Associated Microangiopathy (TAM): Results of a Consensus Process by an International Working Group.

J. Moake, J. George, B. Lämmle, 2005 .

Initial management of immune thrombocytopenic purpura in children: is supportive counseling without therapeutic intervention sufficient?

J. George, 2000, The Journal of pediatrics.

Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura

J. George, Samiksha Gupta, J. Reese, 2021, Blood advances.

Pregnancy‐induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw–Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients

J. George, T. Miyata, K. Kokame, 2009, British journal of haematology.

Clinical insights from observations on ADAMTS13 deficiency in liver cirrhosis.

J. George, 2008, Thrombosis and haemostasis.

Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports.

S. Vesely, J. George, B. Lämmle, 2007, Haematologica.

Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases.

S. Vesely, J. George, Deirdra R. Terrell, 2006, The oncologist.

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)

J. George, R. Shadduck, J. Gryn, 2001, Journal of clinical apheresis.

Dog platelets accumulate intracellular Fibrinogen as they age

J. George, S. Burstein, G. Dale, 1994, Journal of cellular physiology.

Platelet IgG, IgA, IgM, and albumin: correlation of platelet and plasma concentrations in normal subjects and in patients with ITP or dysproteinemia.

J. George, S. Saucerman, 1988, Blood.

Incorporation of a circulating protein into megakaryocyte and platelet granules.

J. George, M. Shuman, D. Bainton, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Immunoglobulin G is a platelet alpha granule-secreted protein.

J. George, D. Bainton, S. P. Levine, 1985, The Journal of clinical investigation.

Additional autoimmune disorders in patients with acquired autoimmune thrombotic thrombocytopenic purpura

J. George, Ayesha Hassan, M. Iqbal, 2019, American journal of hematology.

Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: A case report

J. George, Gregory C Borstad, M. Feldman, 2007, American journal of hematology.

Complications of plasma exchange in thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: a study of 78 additional patients

S. Vesely, J. George, Deirdra R. Terrell, 2003, Transfusion.

Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura.

S. Vesely, J. George, B. Lämmle, 2014, Blood.

Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura.

S. Vesely, J. George, J. K. Kremer Hovinga, 2016, Blood.

ADAMTS13 and TTP: the clot thickens

S. Vesely, J. George, 2004 .

Transient red blood cell aplasia in association with viral hepatitis. Occurrence four years apart in siblings.

J. George, M. Gold, D. Sears, 1975, Archives of internal medicine.

Remission induction in adult acute lymphocytic leukemia. Use of vincristine and prednisone alone

J. George, D. Sears, Hugo Scavino, 1976, Cancer.

Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura

J. George, P. Cobb, J. Reese, 2015, American journal of hematology.

First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur?

S. Vesely, J. George, M. Marques, 2013, Transfusion.

The above letter was sent to George et al.: Dr George offered the following reply.

J. George, 2004 .

Quinine Allergy Causing Acute Severe Systemic Illness: Report of 4 Patients Manifesting Multiple Hematologic, Renal, and Hepatic Abnormalities

S. Vesely, J. George, P. Medina, 2003, Proceedings.

A support group for patients who have recovered from thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome (TTP‐HUS): The six‐year experience of the Oklahoma TTP‐HUS Study Group

S. Vesely, J. George, Deirdra R. Terrell, 2003, Journal of clinical apheresis.

Drug‐associated blood dyscrasias

J. George, P. Medina, 2001 .

Unintentional platelet removal by plasmapheresis

S. Vesely, J. George, J. Smith, 2001, Journal of clinical apheresis.

Glanzmann's thrombasthenia: the spectrum of clinical disease.

J. George, A. Nurden, J P Caen, 1990, Blood.

The use of facoor VIII and factor IX concentrates during surgery.

J. George, R. Breckenridge, 1970, JAMA.

Thrombin decreases von Willebrand factor binding to platelet glycoprotein Ib.

J. George, J. George, M. M. Torres, 1988, Blood.

Bernard‐Soulier Disease: a Study of Four Patients and their Parents

J. Moake, J. George, D. Sears, 1981, British journal of haematology.

Platelet Membrane Glycoproteins

J. George, A. Nurden, D. Phillips, 2012, Springer US.

Platelet membrane glycoproteins: alteration during storage of human platelet concentration.

J. George, 1976, Thrombosis research.

Dose of prophylactic platelet transfusions and prevention of hemorrhage.

Jeffrey McCullough, John R Hess, Paul M Ness, 2010, The New England journal of medicine.

Heterogeneity of platelet secretion in response to thrombin demonstrated by fluorescence flow cytometry.

J. George, R. McEver, G. Johnston, 1987, Blood.

Direct assessment of platelet adhesion to glass: a study of the forces of interaction and the effects of plasma and serum factors, platelet function, and modification of the glass surface.

J. George, 1972, Blood.

An evaluation of cyclosporine alone for the treatment of early recurrences of thombotic thrombocytopenic purpura

J. George, M. Jin, S. Cataland, 2006, Journal of thrombosis and haemostasis : JTH.

Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic‐uremic syndromes

S. Vesely, J. George, B. Lämmle, 2010, American journal of hematology.

Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

J. George, A. Wu, D. Cella, 2008, Health and quality of life outcomes.

Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of alpha-granule proteins.

J. George, 1990, Blood.

Idiopathic Thrombocytopenic Purpura: Lessons from a Guideline

J. George, F. Davidoff, 1997, Annals of Internal Medicine.

Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake.

J. George, Michael McDermott, R. Gilcher, 2002, The New England journal of medicine.

Systemic infections mimicking thrombotic thrombocytopenic purpura

S. Vesely, J. George, Deirdra R. Terrell, 2011, American journal of hematology.

Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G-6-PD deficient subjects.

J. George, M. Conrad, D. Sears, 1967, The Journal of laboratory and clinical medicine.

Studies on platelet plasma membranes. I. Characterization of surface proteins of human platelets labeled with diazotized (125i)-diiodosulfanilic acid.

J. George, D. Sears, P. Lewis, 1976, The Journal of laboratory and clinical medicine.

Treatment of drug-induced thrombocytopenia

J. George, P. Medina, S. D. Zondor, 2002, Expert opinion on drug safety.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

J. George, J. Bussel, C. Kessler, 2008, The Lancet.

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

S. Vesely, J. George, Deirdra R. Terrell, 2004, Blood.

Studies of the mechanism of hemolysis in experimental malaria.

J. George, M. Conrad, E. F. Stokes, 1966, Military medicine.

Drug‐induced thrombocytopenia in children

S. Vesely, J. George, G. Buchanan, 2013, Pediatric blood & cancer.

Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages *

J. George, D. Royer, Deirdra R. Terrell, 2010, European journal of haematology.

Recurrent acute thrombocytopenia in the hospitalized patient: Sepsis, DIC, HIT, or antibiotic‐induced thrombocytopenia

J. George, B. Cowley, I. Aldoss, 2009, American journal of hematology.

Histiocytic medullary reticulosis with parallel increases in serum acid phosphatase and disease activity

J. George, D. Sears, D. White, 1976, Cancer.

How can we provide the best care for our patients with immune thrombocytopenic pupura?

S. Vesely, J. George, 2004, Mayo Clinic proceedings.

Self-Reported Initial Management of Childhood Idiopathic Thrombocytopenic Purpura: Results of a Survey of Members of the American Society of Pediatric Hematology/Oncology, 2001

S. Vesely, J. George, V. Blanchette, 2003, Journal of pediatric hematology/oncology.

Depression and cognitive impairment following recovery from thrombotic thrombocytopenic purpura

James G. Scott, S. Vesely, J. George, 2015, American journal of hematology.

Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.

J. Moake, J. George, B. Lämmle, 2007, Haematologica.

Recent advances in thrombotic thrombocytopenic purpura.

J. Moake, J. George, T. Miyata, 2004, Hematology. American Society of Hematology. Education Program.

Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura.

J. George, J. Nieva, J. Bussel, 2005 .

Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy

S. Vesely, J. George, M. Rizvi, 2004, Annals of Internal Medicine.

Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes?

J. George, 2002, Leukemia research.

Drug-induced thrombocytopenia: a systematic review of published case reports.

J. George, G. Raskob, M. Rizvi, 1998, Annals of internal medicine.

Platelet IgG: measurement, interpretation, and clinical significance.

J. George, 1991, Progress in hemostasis and thrombosis.

The Child With Immune Thrombocytopenic Purpura: Is Pharmacotherapy or Watchful Waiting the Best Initial Management?: A Panel Discussion From the 2002 Meeting of the American Society of Pediatric Hematology/Oncology

J. George, J. Bussel, M. Tarantino, 2004, Journal of pediatric hematology/oncology.

Treatment options for chronic idiopathic (immune) thrombocytopenic purpura.

J. George, 2000, Seminars in hematology.

Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: results of a survey of practicing pediatric hematology/oncology specialists.

S. Vesely, J. George, G. Raskob, 2000, Journal of pediatric hematology/oncology.

Which Drugs Cause Thrombocytopenia

J. George, G. Raskob, M. Rizvi, 1999 .

Idiopathic thrombocytopenic purpura: diagnosis and management.

J. George, G. Raskob, 1998, The American journal of the medical sciences.

Clinical practice. Thrombotic thrombocytopenic purpura.

J. George, James N George, 2006, The New England journal of medicine.

Platelet Counts during Pregnancy

S. Vesely, J. George, J. Peck, 2018, The New England journal of medicine.

Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults.

J. George, G. Raskob, James N. George, 1998, Seminars in hematology.

Clinical decisions in idiopathic thrombocytopenic purpura.

J. George, G. Raskob, 1997, Hospital practice.

Fatigue in adult patients with primary immune thrombocytopenia

S. Vesely, J. George, J. Newton, 2011, European journal of haematology.

Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study

J. George, J. Bussel, A. Newland, 2010 .

For low platelets, how low is dangerous?

J. George, 2004, Cleveland Clinic journal of medicine.

A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia

J. George, J. Kelton, J. Bourgeois, 2013, European journal of haematology.

Effi cacy of romiplostim in patients with chronic immune thrombocytopenic purpura : a double-blind randomised controlled trial

J. George, J. Bussel, C. Kessler, 2008 .

Challenges and priorities for patients with immune thrombocytopenic purpura and their physicians

J. George, 2009 .

Self‐reported health‐related quality of life in adults with chronic immune thrombocytopenic purpura

J. George, J. Bussel, R. Mcmillan, 2008, American journal of hematology.

Phosphorylation of thymus myosin increases its apparent affinity for actin but not its maximum adenosinetriphosphatase rate.

J. George, P. Wagner, 1986, Biochemistry.

Syndromes of thrombotic microangiopathy.

J. George, Carla M Nester, James N George, 2014, The New England journal of medicine.

Platelet counts in women with normal pregnancies: A systematic review

S. Vesely, J. George, J. Peck, 2017, American journal of hematology.

Human platelet surface binding of endogenous secreted factor VIII-von Willebrand factor and platelet factor 4.

J. George, A. Onofre, 1982, Blood.

Platelet activation and secretion associated with emotional stress.

J. George, S. P. Levine, L. K. Knieriem, 1985, Circulation.

ADAMTS13, thrombotic thrombocytopenic purpura, and hemolytic uremic syndrome.

J. George, 2005, Current hematology reports.

Thrombotic thrombocytopenic purpura. Occurrence two years apart during late pregnancy in two sisters.

J. George, D. Sears, L. Dotin, 1976, JAMA.

N‐Acetylcysteine: an old drug, a new insight, a potentially effective treatment for thrombotic thrombocytopenic purpura

J. George, B. Konkle, José A López, 2014, Transfusion.

Studies on platelet plasma membranes. III. Membrane glycoprotein loss from circulating platelets in rabbits: inhibition by aspirin-dipyridamole and acceleration by thrombin.

J. George, P. Lewis, 1978, The Journal of laboratory and clinical medicine.

Prevalence of primary immune thrombocytopenia in Oklahoma

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.

S. Vesely, J. George, B. Lämmle, 2003, Blood.

How I treat patients with thrombotic thrombocytopenic purpura: 2010.

J. George, James N George, 2010, Blood.

Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim

J. George, J. Thachil, I. Salter, 2013, European journal of haematology.

A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial.

J. George, J. Bussel, R. Mcmillan, 2007, Clinical therapeutics.

Platelet Immunobiology: Molecular and Clinical Aspects

J. George, T. Kunicki, 1989 .

Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology.

J. George, G. Raskob, S. Woolf, 1998, Annals of medicine.

Drug (vaccine)‐induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features

J. George, B. Curtis, J. Reese, 2022, American journal of hematology.

Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant‐associated thrombotic microangiopathy (BMT‐TM)

J. George, J. Nemunaitis, J. Raymond, 1996, American journal of hematology.

Hereditary Thrombotic Thrombocytopenic Purpura. Reply.

J. George, J. K. Kremer Hovinga, 2020 .

Survival and relapse in patients with thrombotic thrombocytopenic purpura.

S. Vesely, J. George, B. Lämmle, 2010, Blood.

Conflicts of Interest and Clinical Recommendations

S. Vesely, J. George, S. Woolf, 2014, American journal of medical quality : the official journal of the American College of Medical Quality.

Determining a definite diagnosis of primary immune thrombocytopenia by medical record review

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

Referral of patients with thrombocytopenia from primary care clinicians to hematologists.

S. Vesely, J. George, L. Beebe, 2009, Blood.

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

S. Vesely, J. George, M. Hauben, 2010, Blood.

A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation

J. George, J. Bussel, R. Mcmillan, 2007, Health and quality of life outcomes.

Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer.

S. Vesely, J. George, B. Lämmle, 2012, Presse medicale.

Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune‐mediated disorders

S. Vesely, J. George, J. Kiss, 2006, Journal of clinical apheresis.

Thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma

S. Vesely, J. George, G. Selby, 2004, Transfusion.

Definition, diagnosis and treatment of immune thrombocytopenic purpura

J. George, James N George, 2009, Haematologica.

Irinotecan-induced immune thrombocytopenia.

J. George, R. Aster, B. Curtis, 2014, The American journal of the medical sciences.

Evidence-based medicine. Interpreting studies and setting policy.

J. George, S. Woolf, 2000, Hematology/oncology clinics of North America.

Syndromes of thrombotic microangiopathy associated with pregnancy.

J. George, C. Nester, J. Mcintosh, 2015, Hematology. American Society of Hematology. Education Program.

Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review

S. Vesely, J. George, M. Abu-Fadel, 2007, Transfusion.

in a prospective cohort of 142 patients uremic syndrome: relation to presenting features and clinical outcomes hemolytic - ADAMTS13 activity in thrombotic thrombocytopenic purpura

S. Vesely, J. George, B. Lämmle, 2013 .

Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura

S. Vesely, J. George, B. Lämmle, 2015, PloS one.

Occult quinine-induced thrombocytopenia.

J. George, P. Medina, K. Kojouri, 2000, The Journal of the Oklahoma State Medical Association.

Membrane Glycoprotein Loss from Circulating Platelets: Inhibition by Dipyridamole and Aspirin

J. George, P. Lewis, 1977, Thrombosis and Haemostasis.

Platelet membrane glycoproteins: historical perspectives

J. George, D. Phillips, A. Nurden, 2006, Journal of thrombosis and haemostasis : JTH.

Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008

S. Vesely, J. George, Deirdra R. Terrell, 2009, Transfusion.

Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.

S. Vesely, J. George, D. Little, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research.

J. George, 2004, Transfusion.

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

J. George, P. Medina, J. Sīpols, 2001, Current opinion in hematology.

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.

J. George, Jordan Morton, 2016, Journal of oncology practice.

Thrombotic Microangiopathy After Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Study

J. George, G. Selby, Z. Laszik, 2008, Transplantation.

Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression.

J. George, S. Burstein, G. Dale, 1994, Blood.

Use of caplacizumab in a child with refractory thrombotic thrombocytopenic purpura

J. George, J. Hankins, Alex Ryder, 2019, Pediatric blood & cancer.

Hereditary Thrombotic Thrombocytopenic Purpura.

J. George, J. K. Kremer Hovinga, 2019, The New England journal of medicine.

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and treatment.

J. George, S. Vesely, 2001, Cleveland Clinic journal of medicine.

Occurrence of immune thrombocytopenic purpura in patients with nonhematologic cancers: A systematic review of clinical evidence from case reports

S. Vesely, J. George, A. Tfayli, 2008 .

Drug-induced thrombotic microangiopathy: a systematic review of published reports.

S. Vesely, J. George, Deirdra R. Terrell, 2015, Blood.

Cognitive deficits after recovery from thrombotic thrombocytopenic purpura

James G. Scott, S. Vesely, J. George, 2009, Transfusion.

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.

James Allison, Stephen Forman, Massimo Cristofanilli, 2015, Mayo Clinic proceedings.

Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura.

S. Vesely, J. George, B. Lämmle, 2013, Blood.

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura.

J. George, S. Geyer, S. Cataland, 2017, Blood advances.

Drug‐induced thrombotic microangiopathy: An updated systematic review, 2014‐2018

J. George, R. Saleem, J. Reese, 2018, American journal of hematology.

Drug‐induced thrombotic microangiopathy: Experience of the Oklahoma registry and the BloodCenter of Wisconsin

S. Vesely, J. George, R. Aster, 2015, American journal of hematology.

Studies of in vitro primaquine hemolysis: substrate requirement for erythrocyte membrane damage.

J. George, W. Crosby, S. Pollack, 1966, The Journal of clinical investigation.

Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device

J. George, R. Aster, M. Cherry, 2015, Transfusion.

TTP: long-term outcomes following recovery.

J. George, 2018, Hematology. American Society of Hematology. Education Program.

Thrombotic Thrombocytopenic Purpura

J. George, 1988 .

Long-term Kidney Outcomes in Patients With Acquired Thrombotic Thrombocytopenic Purpura

S. Vesely, J. George, J. K. Kremer Hovinga, 2017, Kidney international reports.

Leukaemoid reactions in myeloproliferative diseases. Report of two patients.

J. George, D. Sears, D. R. White, 2009, Scandinavian journal of haematology.

Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura.

S. Vesely, J. George, J. K. Kremer Hovinga, 2016, Blood.

Long‐term deficits in health‐related quality of life after recovery from thrombotic thrombocytopenic purpura

S. Vesely, J. George, Deirdra R. Terrell, 2009, Transfusion.

Frequency and severity of pregnancy complications in women with hereditary thrombotic thrombocytopenic purpura

J. George, A. Borogovac, Rana Kasht, 2020, American journal of hematology.

Drug-Induced Thrombocytopenia

S. Vesely, J. George, Xiaoning Li, 2009, Drug safety.

Drug-induced thrombocytopenia: an updated systematic review, 2012.

J. George, Z. Al-Nouri, 2012, Drug Safety.

Drug-induced thrombocytopenia: an updated systematic review.

J. George, M. Rizvi, K. Kojouri, 2001, Annals of internal medicine.

Diagnosis, clinical course, and management of idiopathic thrombocytopenic purpura

J. George, 1996, Current opinion in hematology.

Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia.

J. George, A. Borogovac, 2019, Blood advances.

Congenital thrombotic thrombocytopenic purpura: Lessons for recognition and management of rare syndromes

J. George, 2008, Pediatric blood & cancer.

An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.

J. George, E. Kraut, A. Ferketich, 2007, British journal of haematology.

International Registry for Patients with Hereditary Thrombotic Thrombocytopenic Purpura (TTP) – Upshaw-Schulman Syndrome

J. George, B. Lämmle, Y. Fujimura, 2012 .

Drug-Induced Thrombocytopenia

Long T. Nguyen, J. George, J. Reese, 2011, Drug safety.

The Frequency of Rheumatic Disease Autoantibodies in Patients with ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

S. Vesely, J. George, B. Lämmle, 2007 .

After the Party's Over.

J. George, C. Nester, J. M. Morton, 2017, The New England journal of medicine.

A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP‐HUS Registry

S. Vesely, J. George, 2012, Transfusion.

Diversity and severity of adverse reactions to quinine: A systematic review

S. Vesely, J. George, G. Raskob, 2016, American journal of hematology.

Immune Thrombocytopenia Treatment.

J. George, P. Bolton-Maggs, 2021, The New England journal of medicine.

Acute autoimmune hemolytic anemia due to a low molecular weight IgM cold hemolysin associated with episodic lymphoid granulomatous vasculitis.

J. George, D. Sears, D. Spiva, 1974, The American journal of medicine.

Long‐term outcomes of health‐related quality of life following diverse thrombotic microangiopathy syndromes

S. Vesely, J. George, Deirdra R. Terrell, 2016, American journal of hematology.

Platelet sequestration and consumption in the placental intervillous space contribute to lower platelet counts during pregnancy

S. Vesely, J. George, J. Peck, 2018, American journal of hematology.

Drug‐induced thrombocytopenia: 2019 Update of clinical and laboratory data

J. George, B. Curtis, J. Reese, 2018, American journal of hematology.

Cobalamin C deficiency-associated thrombotic microangiopathy: uncommon or unrecognised?

J. George, 2015, The Lancet.

Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.

S. Vesely, J. George, L. Williams, 2006, Transfusion.

Quebec platelet syndrome: from the bench to the family

J. George, 2004 .

Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets.

J. George, M. Blajchman, E. Genton, 1981, The Journal of clinical investigation.

Neurocognitive Impairment Following Recovery from ADAMTS13-Deficient Thrombotic Thrombocytopenia Purpura (TTP).

James G. Scott, S. Vesely, J. George, 2007 .

Sporadic Bloody Diarrhea-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) in Adults in Oklahoma: Comparison to Adults with Severe Adamts13 Deficiency and to Children with Typical HUS.

S. Vesely, J. George, B. Lämmle, 2007 .

The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service.

S. Vesely, J. George, R. Gilcher, 2007, The Journal of the Oklahoma State Medical Association.

Predicting Risk for Relapse in Patients Who Have Recovered from Thrombotic Thrombocytopenic Purpura (TTP).

S. Vesely, J. George, B. Lämmle, 2006 .

Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura–hemolytic uremic syndrome: 2011 to 2014

S. Vesely, J. George, Deirdra R. Terrell, 2014, Transfusion.

Prostatic Monocyte Chemotactic Protein-1 (MCP-1): A Novel Potential Biomarker for Symptomatic Benign Prostatic Hyperplasia

J. George, K. Fujita, M. Charles, 2017 .

Hereditary thrombotic thrombocytopenic purpura and COVID‐19: Impacts of vaccination and infection in this rare disease

J. George, B. Lämmle, K. Friedman, 2022, Research and Practice in Thrombosis and Haemostasis.

Children with ITP: Looking beyond the platelet count

J. George, 2012, Pediatric blood & cancer.

Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives

S. Vesely, J. George, J. Guidry, 2009, European Journal of Haematology.

Idiopathic thrombocytopenic purpura in adults: current issues for pathogenesis, diagnosis and management.

J. George, 2004, The hematology journal : the official journal of the European Haematology Association.

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP)

J. George, R. Shadduck, J. Gryn, 2001, Journal of clinical apheresis.

Acute bleeding and thrombocytopenia after bone marrow transplantation

J. George, C. Enger, H. Braine, 2001, Bone Marrow Transplantation.

Hereditary thrombotic thrombocytopenic purpura and the hereditary TTP registry.

J. George, B. Lämmle, P. Knöbl, 2013, Hamostaseologie.

Immunoglobulin G Is a Platelet Alpha Granule-secreted Protein

J. George, S. P. Levine, Sherry Saucerman, 2022 .

Recognizing Hereditary TTP in Infants and Children

J. George, J. Journeycake, A. Siddiqui, 2020 .

Hereditary Thrombotic Thrombocytopenic Purpura.

J. George, J. K. Kremer Hovinga, 2019, The New England journal of medicine.

Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura

J. George, G. Soff, L. Boiocchi, 2022, American journal of hematology/oncology.

Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura

J. George, J. Bussel, J. Christal, 2007 .

Workshop on autoimmune (idiopathic) thrombocytopenic purpura: Pathogenesis and new approaches to therapy

J. George, R. Aster, R. Mcmillan, 1998, American journal of hematology/oncology.

Successful treatment of cyclic thrombocytopenia with thrombopoietin‐mimetic agents: A report of two patients

J. George, F. Magrini, A. Cortelezzi, 2009, American journal of hematology.

Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective

J. George, A. Wu, D. Cella, 2008, Health and quality of life outcomes.

Should all adult patients with diarrhoea-associated HUS receive plasma exchange?

J. George, P. Tarr, W. Chandler, 2012, The Lancet.

The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports

S. Vesely, J. George, L. Beebe, 2010, American journal of hematology.

Glanzmann's thrombasthenia: the spectrum of clinical disease.

J. George, A. Nurden, J. Caen, 1990, Blood.

Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency

S. Vesely, J. George, B. Lämmle, 2011, Transfusion.

Congenital TTP: toward a turning point.

J. George, 2019, Blood.

Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

J. George, L. Aledort, M. Tarantino, 2010, Journal of thrombosis and haemostasis : JTH.

Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.

S. Vesely, J. George, D. Little, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Drug-Induced Thrombocytopenia

J. George, G. Raskob, M. Rizvi, 1998, Annals of Internal Medicine.

Prevalence of primary immune thrombocytopenia in Oklahoma

S. Vesely, J. George, L. Beebe, 2012, American journal of hematology.

Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.

J. George, S. Cataland, M. Loch, 2019, New England Journal of Medicine.

Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States

J. George, P. Wahl, B. Ewenstein, 2012, Transfusion.

Corticosteroids and rituximab as adjunctive treatments for thrombotic thrombocytopenic purpura

J. George, 2012, American journal of hematology.

Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura

J. George, Shili Lin, E. Kraut, 2009, European Journal of Haematology.

Preventable deaths during initial episodes of acquired Thrombotic Thrombocytopenic Purpura: Past and future

J. George, Cynthia K Saliba, 2019, American journal of hematology.

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer.

J. George, Jordan Morton, 2016, Journal of oncology practice.

Fatigue in adult patients with primary immune thrombocytopenia

S. Vesely, J. George, J. Newton, 2011, European journal of haematology.

Heinz body hemolytic anemias.

J. George, R. Weed, D. Miller, 1970, New York state journal of medicine.